The Mercator Medical Group expects a significant increase in EBITDA and net profit in the second quarter of 2026.

The Mercator Medical Group, a manufacturer of disposable gloves and distributor of medical supplies, reported estimated sales revenue of PLN 191 million for the second quarter of 2026, representing a 33 per cent year-on-year increase. Estimated consolidated EBITDA stood at PLN 46 million, compared with a loss of PLN 6.1 million in the second quarter of last year, whilst the Group’s net profit rose to PLN 44.4 million, compared with a loss of PLN 9.3 million in the corresponding period of 2025. The improvement in results was primarily due to higher margins on product sales, increased sales of specialist and premium gloves, and more favourable purchase prices for goods.

The Group’s results were influenced by both operational factors and market conditions. In the second quarter, geopolitical tensions in the Strait of Hormuz played a significant role, affecting the supply and demand situation in the market for gloves and other personal protective equipment. This led to a rise in the prices of diagnostic gloves and non-woven products. At the same time, the Group increased the sales volume of its own-brand gloves, expanded sales of selected glove categories in the retail segment, and continued to grow in the area of non-woven products. In parallel, it broadened its range to include new product groups, thereby strengthening the diversification of its portfolio.

- We have had a good second quarter, in which we recorded an increase in revenue and an improvement in EBITDA and net profit. A key factor in the improvement in financial performance was the market situation, which created scope for more effective management of prices and margins. In such conditions, a swift response to changes in demand and a flexible commercial policy were crucial. More favourable purchasing terms compared with the same period last year also had a positive impact on margins. At the same time, we are consistently increasing the share of higher value-added products, including specialist and premium gloves. At the same time, we are expanding our product portfolio, increasing revenue diversification and the Group’s resilience to changing market conditions – says Monika Żyznowska, Chair of the Management Board of Mercator Medical S.A.

At the end of June 2026, the Mercator Group held approximately PLN 171.4 million in net cash and other financial assets.

This stable financial position enables the Group to carry out key investment projects, including the further development of the property segment through Mercator Estates. The company is continuing to deliver a number of projects in the premium and medium-plus segments, focusing on architectural quality, functionality and the effective utilisation of the location’s potential. Recently, Mercator Estates obtained final planning permission for a development involving the regeneration of historic tenement blocks at the junction of Lubicz and Westerplatte streets in Kraków. The project involves the construction of 72 flats, a two-storey underground car park, commercial premises and a green patio, with completion scheduled for 2027–2029. At the same time, the company is working on further projects, including a new development concept for the property on Paderewskiego Street in Katowice.

The Mercator Group continues to pursue a responsible policy towards its shareholders. At the beginning of August, a dividend was paid to the shareholders of Mercator Medical S.A. In accordance with the resolution of the Annual General Meeting of 30 June 2026, PLN 15 million was allocated for this purpose, amounting to PLN 1.64 gross per share. The dividend was paid out of the profit generated in 2025, amounting to PLN 6.1 million, and from retained earnings from previous years totalling PLN 8.9 million.

The figures presented are preliminary and estimated. The Mercator Medical Group’s consolidated half-yearly report for the first half of 2026 is currently being prepared. Publication is scheduled for 30 September 2026.

***

The Mercator Medical Group, based in Kraków, is a manufacturer of disposable gloves and a distributor of single-use medical supplies. It is one of the leading players in Poland and a significant player on the international stage. The company’s history dates back to 1989. The Mercator Medical Group operates a production centre in Thailand and is involved in distribution, including products from third-party suppliers. Its operations are international in scope – sales through its own distribution companies and via external, local distributors take place in several dozen countries around the world; in 2025, the Group sold almost 5.9 billion disposable gloves. Since November 2013, Mercator Medical S.A. shares have been listed on the regulated market of the Warsaw Stock Exchange. In March 2021, they were included in the main stock market index – the WIG20; they are currently listed on the sWIG80 index.

In 2024, Monika Żyznowska, CEO of Mercator Medical, was appointed to the Issuers’ Council under the President of the Warsaw Stock Exchange.